Sulindac FDA Link Generic

A sulfinylindene derivative prodrug whose sulfinyl moiety is converted in vivo to an active NSAID analgesic. Specifically, the prodrug is converted by liver enzymes to a sulfide which is excreted in the bile and then reabsorbed from the intestine. This helps to maintain constant blood levels with reduced gastrointestinal side effects.

Also Known As:

Copal; Clinoril; Aclin; Apo-Sulin; Arthrobid; Arthrocine; Chibret; Kenalin; Klinoril; MK-231; Novo-Sundac; Nu-Sulindac; Sulindal; Apo Sulin; MK 231; MK231; Novo Sundac; Nu Sulindac; 1H-Indene-3-acetic acid, 5- fluoro- 2- methyl- 1- ((4- (methylsulfinyl)phenyl)methylene)- , (Z)-

Pharmalogical Action Categories:

Anti-Inflammatory Agents, Non-Steroidal
Antineoplastic Agents
Cyclooxygenase Inhibitors

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Indenes: 4
        Sulindac: 994
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Indenes: 4
    - Sulindac: 994

Steven Goldschmid Selected Research

Steven Goldschmid Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure